Immunic (IMUX) Short Interest Ratio & Short Volume → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free IMUX Stock Alerts $1.24 0.00 (0.00%) (As of 04:28 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Immunic Short Interest DataCurrent Short Volume3,030,000 sharesPrevious Short Volume2,470,000 sharesChange Vs. Previous Month+22.67%Dollar Volume Sold Short$4.00 millionShort Interest Ratio / Days to Cover3.1Last Record DateMarch 31, 2024Outstanding Shares89,930,000 sharesPercentage of Shares Shorted3.37%Today's Trading Volume129,283 sharesAverage Trading Volume849,290 sharesToday's Volume Vs. Average15% Short Selling Immunic ? Sign up to receive the latest short interest report for Immunic and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIMUX Short Interest Over TimeIMUX Days to Cover Over TimeIMUX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Immunic Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20243,030,000 shares $4.00 million +22.7%N/A3.1 $1.32 3/15/20242,470,000 shares $3.24 million +11.3%N/A2.5 $1.31 2/29/20242,220,000 shares $3.25 million -11.9%N/A2.4 $1.47 2/15/20242,520,000 shares $3.38 million -2.7%N/A2.9 $1.34 1/31/20242,590,000 shares $3.08 million -20.6%N/A3.3 $1.19 1/15/20243,260,000 shares $4.17 million +48.2%N/A4.2 $1.28 Get the Latest News and Ratings for IMUX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. 12/31/20232,200,000 shares $3.30 million -6.4%N/A1.9 $1.50 12/15/20232,350,000 shares $3.53 million -15.2%N/A2.9 $1.50 11/30/20232,770,000 shares $3.30 million -6.4%N/A3.5 $1.19 11/15/20232,960,000 shares $2.96 million -9.5%N/A3.8 $1.00 10/31/20233,270,000 shares $3.47 million -24.7%N/A4.1 $1.06 10/15/20234,340,000 shares $5.25 million +77.9%N/A5.4 $1.21 9/30/20232,440,000 shares $3.59 million -2.4%N/A3 $1.47 9/15/20232,500,000 shares $3.58 million +4.6%N/A2.7 $1.43 8/31/20232,390,000 shares $3.99 million +11.7%N/A2.5 $1.67 8/15/20232,140,000 shares $3.66 million +7.5%N/A2.1 $1.71 7/31/20231,990,000 shares $4.80 million -2.0%N/A1.9 $2.41 7/15/20232,030,000 shares $5.14 million -6.5%N/A1.9 $2.53 6/30/20232,170,000 shares $5.45 million +6.9%N/A2.1 $2.51 6/15/20232,030,000 shares $3.35 million -12.9%N/A1.9 $1.65 5/31/20232,330,000 shares $3.84 million -28.3%N/A2 $1.65 5/15/20233,250,000 shares $5.72 million -11.0%N/A2.6 $1.76 4/30/20233,650,000 shares $6.06 million -14.7%N/A2.8 $1.66 4/15/20234,280,000 shares $6.12 million +3.1%N/A3 $1.43 3/31/20234,150,000 shares $6.18 million -5.7%N/A2.7 $1.49 3/15/20234,400,000 shares $7.22 million -21.7%N/A4.4 $1.64 2/28/20235,620,000 shares $11.13 million +4.9%N/A5.6 $1.98 2/15/20235,360,000 shares $11.36 million -10.2%N/A5.6 $2.12 1/31/20235,970,000 shares $14.33 million -13.9%N/A5.5 $2.40 1/15/20236,930,000 shares $10.67 million -2.0%N/A3.6 $1.54 12/30/20227,070,000 shares $9.90 million -1.7%N/A1.8 $1.40 12/15/20227,190,000 shares $8.63 million +2.1%N/A1.9 $1.20 11/30/20227,040,000 shares $9.43 million +0.7%N/A1.9 $1.34 11/15/20226,990,000 shares $10.35 million -0.9%N/A1.9 $1.48 10/31/20227,050,000 shares $12.48 million +92.6%N/A2.1 $1.77 10/15/20223,660,000 shares $36.71 million +418.7%N/A1.2 $10.03 9/30/2022705,600 shares $2.23 million -20.9%N/A0.8 $3.16 9/15/2022892,200 shares $3.57 million -3.2%N/A5.5 $4.00 8/31/2022921,200 shares $4.10 million -5.3%N/A4.4 $4.45 8/15/2022972,600 shares $5.34 million -7.4%N/A1.4 $5.49Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him IMUX Short Interest - Frequently Asked Questions What is Immunic's current short interest? Short interest is the volume of Immunic shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 3,030,000 shares of IMUX short. Learn More on Immunic's current short interest. What is a good short interest ratio for Immunic? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMUX shares currently have a short interest ratio of 3.0. Learn More on Immunic's short interest ratio. Is Immunic's short interest increasing or decreasing? Immunic saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 3,030,000 shares, an increase of 22.7% from the previous total of 2,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Immunic's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Immunic: Cartesian Therapeutics, Inc. (5.31%), CytomX Therapeutics, Inc. (4.90%), OptiNose, Inc. (2.76%), Seres Therapeutics, Inc. (12.45%), Rezolute, Inc. (0.63%), Societal CDMO, Inc. (0.00%), Adagene Inc. (0.04%), Nuvectis Pharma, Inc. (12.12%), Coya Therapeutics, Inc. (1.53%), FibroGen, Inc. (5.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Immunic stock? Short selling IMUX is an investing strategy that aims to generate trading profit from Immunic as its price is falling. IMUX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immunic? A short squeeze for Immunic occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMUX, which in turn drives the price of the stock up even further. How often is Immunic's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMUX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: RNAC Short Squeeze CTMX Short Squeeze OPTN Short Squeeze MCRB Short Squeeze RZLT Short Squeeze SCTL Short Squeeze ADAG Short Squeeze NVCT Short Squeeze COYA Short Squeeze FGEN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMUX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceThe Greatest Bull Market in Crypto History…Weiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry